Skip to main content

Home

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Inaphaea BioLabs
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us

Annual and Half Yearly Reports

Breadcrumb

  1. Investors
  2. AIM Rule 26
  3. Annual and Half Yearly Reports
Half Yearly Report For the Period Ended 30 June 2022. 357.53 KB
Valirx Annual Reports & Accounts For The Year Ended December 2021 2.29 MB
Half Yearly Report For the Period Ended 30 June 2021 & Investor Presentation 3.85 MB
Report & Accounts For The Year Ended 31 December 2020 5.29 MB
Half Yearly Report For The Period Ended 30 June 2020 301.29 KB
Reports & Accounts For The Year Ended 31 December 2019 279.65 KB
Half Yearly Report For The Period Ended 30 June 2019 273.2 KB
Report & Accounts For The Year Ended 31 December 2018 2.66 MB
Half yearly report for the period ended 30 June 2018 197.19 KB
Reports & Accounts For The Year Ended 31 December 2017 1.46 MB
Half Yearly Report For The Period Ended 30 June 2017 207.25 KB
Report & Accounts For The Year Ended 31 December 2016 2.13 MB

Pagination

  • Current page 1
  • Page 2
  • Next page ››
  • Last page Last »
ValiRx PLC

Contact us

ValiRx Plc
Eliot Park Innovation Centre
4 Barling Way
Nuneaton, CV10 7RH
UK

Tel: +44 (0)2476 796496
Email: info@valirx.com

Registered in England and Wales

Company Number: 3916791
VAT Number: 756 3180 24

UK Registered Office Address
Stonebridge House, Chelmsford Road, Hatfield Heath, England, CM22 7BD

Links

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Inaphaea BioLabs
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us
Terms and Conditions Privacy Policy Accessibility Compliance Corporate Governance Corporate Social Responsibility

Site and its contents Copyright © ValiRx PLC 2023. All rights reserved.
Website Design and Development by Sciad Communications Ltd